Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma

Journal of Investigative Dermatology(2021)10.1016/j.jid.2021.04.023Source: DataRank Database

Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma is a research paper published in Journal of Investigative Dermatology (2021). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 4.23)OA: bronzeTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Christina C. Patrone ORCID,S. Aidan Quinn ORCID,Yuhan Gu,Marta Sánchez-Martín ORCID,Adam L. Mackey ORCID

Live enrichment

PubMed:34089720 PMC:PMC9020801 OpenAlex:https://openalex.org/W3168367048

Leukemia and Lymphoma Society

Grant: TRP-6507-17

National Cancer Institute

Grant: 5P50CA192937-03 DRP

National Cancer Institute

Grant: R01 CA197945

NCI NIH HHS

Grant: P30 CA013696

NCI NIH HHS

Grant: P50 CA192937

NCI NIH HHS

Grant: U01 CA243073

National Institutes of Health

Columbia University Irving Medical Center

Lady Tata Memorial Trust

Leids Universitair Medisch Centrum

Mystic Seaport Museum

Actelion Pharmaceuticals

FWCI

4.23

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttps://www.jidonline.org/article/S0022-202X(21)01308-7/pdf

publisherhttps://www.jidonline.org/article/S0022-202X(21)01308-7/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022202X21013087?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022202X21013087?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jid.2021.04.023

Fields of Study

Cutaneous lymphoproliferative disorders researchPhytochemical compounds biological activitiesT-cell and Retrovirus StudiesAnimalsAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorDepsipeptidesDrug SynergismHumansJanus Kinase InhibitorsLymphoma, T-Cell, CutaneousMechlorethamineMiceSTAT Transcription FactorsSignal TransductionSkin Neoplasms

MeSH Terms

Janus Kinase InhibitorsAnimalsAntineoplastic Combined Chemotherapy ProtocolsDrug SynergismHumansMechlorethamineSkin NeoplasmsSignal TransductionLymphoma, T-Cell, CutaneousCell Line, TumorDepsipeptidesSTAT Transcription FactorsMice

Keywords

RomidepsinCancer researchLymphomaBCL10Cutaneous T-cell lymphomaMedicineBiologyMycosis fungoidesImmunologyHistone deacetylaseHistone

Sustainable Development Goals

SDG 0: Good health and well-being